Back to 2026-03 archive
Catalayer News Archive for March 10, 2026
40 public Catalayer analysis articles for this date.
Federal Reserve Board announces termination of enforcement actions with Industrial and Commercial Bank of China Ltd., Industrial and Commercial Bank of China Ltd., New York Branch, Standard Chartered PLC, and Standard Chartered BankSo What Does 2026 Have in Store for the Economy and the Stock Market? - The Greenwich SentinelHome Sales Perk Up as Housing Affordability Improves - National Association of REALTORS®NIO Inc. Reports Unaudited Fourth Quarter and Full Year 2025 Financial Results - NIO - HomeAs Iran war disrupts oil prices, consumers could be 'hammered,' economist says - CNBCMilitary AI Policy by Contract: The Limits of Procurement as Governance - LawfareA top economist warns of a 'significant' recession in 2027 as stimulus and AI investment dries up - Business InsiderIt all started in 1933 when the government confiscated Americans’ gold. Since then, we’ve had: • Endless money printing • A dollar that buys far less every decade • “Temporary” policies that never end Some lessons from history are worth remembering. Gold a - LinkedInThe Forces Driving M&A on Main Street - Third WayHome Sales Perk Up as Housing Affordability Improves - National Association of REALTORS®MSX wants to make SpaceX shareholders accessible to the general public. - BinanceGoogle and OpenAI employees back Anthropic in a legal fight with the Pentagon - FortuneCommodity Futures Positioning: Gold, Silver, Crude Oil | COT r… - StoneXFDA reconsidering Capricor’s snubbed DMD cell therapy after 'lifting' rejection - Fierce BiotechGold, silver sharply up on safe-haven bids, weaker USDX - KITCO'Investing in people': Can China's new push to boost spending revive the economy? - BBCXenon hits a ‘home run’ in epilepsy; FDA restarts review of Duchenne cell therapy - BioPharma DiveManic Monday: US stocks erase a big early loss after oil price whiplash - CommBankVertex races to FDA after phase 3 kidney disease data impress analysts - Fierce BiotechThe Iran Conflict Ended Sub-6% Mortgage Rates. But That's Not the Real Reason Many Can't Buy - U.S. News MoneySilver: Break Toward $90 Could Confirm a Broader Metals Breakout - Investing.comBOJ to raise interest rates next quarter with expectations unchanged by Middle East war: Reuters poll - ReutersAnthropic dispute points to lack of regulations in use of AI in war - San Francisco ExaminerAnthropic Claude Is Bringing Something New to AI: The Power to Say No - BloombergGoogle and OpenAI employees back Anthropic in a legal fight with the Pentagon - FortuneCurrent price of Ethereum for March 10, 2026 - FortuneGoogle and OpenAI employees back Anthropic in a legal fight that could redefine military use of AI - FortuneWar with Iran delivers another shock to the global economy - The Times of IsraelFinancial markets 'sleepwalking into a storm' as money trumps logic - Australian Broadcasting CorporationVolkswagen Group strengthens financial resilience in 2025 – strong fourth quarter in a challenging environment - Volkswagen GroupKevin Warsh faces an economic 'perfect storm' as he waits to take over as Fed chair - CNBCOracle Announces Fiscal Year 2026 Third Quarter Financial Results - PR NewswireOracle stock jumps 10% on earnings beat and increased guidance as cloud revenue climbs 44% - CNBCWar with Iran delivers another shock to the global economy - The Times of IsraelReal Estate vs. Stock Market: Which Is the Better Investment Right Now, According to Financial Experts? - Realtor.comHigher Oil Prices Could Put the Fed in a Bind as Labor Market Softens - The New York TimesGeopolitical conflict and its impact on global markets - U.S. BankOracle stock jumps 10% on earnings beat and increased guidance as cloud revenue climbs 44% - CNBCOracle Announces Fiscal Year 2026 Third Quarter Financial Results - Oracle - Investor RelationsGPS jamming: The invisible battle in the Middle East